When did FUSION PHARMACEUTICALS INC (FUSN) report earnings last quarter?
FUSION PHARMACEUTICALS INC (FUSN) last reported earnings on 5/7/2024.
FUSION PHARMACEUTICALS INC (FUSN) Earnings History & Surprises
NASDAQ:FUSN • CA36118A1003
Current stock price
21.55 USD
+0.03 (+0.14%)
At close:
21.65 USD
+0.1 (+0.46%)
After Hours:
FUSN Earnings overview
Past quarterly earnings results for FUSION PHARMACEUTICALS INC (FUSN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Aug 6, 2024
- Period
- Q2 / 2024
- EPS Estimate
- -$0.37
- Revenue Estimate
- 162.517K
Last Reported
Most Recent- Release Date
- May 7, 2024
- Period
- Q1 / 2024
- EPS Reported
- -$0.40
- EPS Surprise
- -5.51%
- Revenue Surprise
- -100.00%
Beat Rate
Last 8 Quarters 50%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2024 | -0.40 | -0.38 | -5.51% | 11.11% | 154.867K | -100.00% | -100.00% | |
| Q4 2023 | -0.39 | -0.34 | -13.32% | 29.09% | 418.098K | -100.00% | -100.00% | |
| Q3 2023 | -0.25 | -0.41 | 38.59% | 54.55% | 2.006M | 97.471K | 1,958.04% | 1,080.00% |
| Q2 2023 | -0.38 | -0.40 | 4.20% | 13.64% | 34K | 86.068K | -60.50% | -94.04% |
| Q1 2023 | -0.45 | -0.32 | -38.95% | 2.17% | 28K | 8.743M | -99.68% | -95.25% |
| Q4 2022 | -0.55 | -0.57 | 3.02% | -37.50% | 140K | 17.34K | 707.38% | -76.27% |
| Q3 2022 | -0.55 | -0.51 | -7.84% | -22.22% | 170K | 102K | 66.67% | -48.48% |
| Q2 2022 | -0.44 | -0.54 | 18.99% | 30.16% | 570K | 140.25K | 306.42% | 9.62% |
| Q1 2022 | -0.46 | -0.49 | 6.05% | -9.52% | 590K | 1.148M | -48.61% | - |
| Q4 2021 | -0.40 | -0.48 | 15.97% | -25.00% | 590K | - | - | |
| Q3 2021 | -0.45 | -0.61 | 26.22% | -87.50% | 330K | - | - | |
| Q2 2021 | -0.63 | -0.40 | -58.37% | 78.93% | 520K | - | - | |
| Q1 2021 | -0.42 | -0.30 | -40.38% | - | - | - | ||
| Q4 2020 | -0.32 | -0.20 | -62.97% | - | 3.4M | -100.00% | - | |
| Q3 2020 | -0.24 | -0.14 | -68.07% | - | - | - | ||
| Q2 2020 | -2.99 | -0.51 | -486.27% | - | - | - | ||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
5.99%
Max EPS beat (4)
38.59%
Min EPS beat (4)
-13.32%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
424.39%
Max Revenue beat (4)
1,958.04%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, FUSN has beaten EPS estimates in 2 out of 4 releases
FUSN has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, FUSN has beaten the EPS estimates by 6.0% on average.
In the last 4 quarters, FUSN has beaten the revenue estimates by 424.4% on average.
Related analysis
FUSION PHARMACEUTICALS INC / FUSN Earnings FAQ
Can you provide information on whether FUSION PHARMACEUTICALS INC beat earnings estimates in the last quarter?
FUSION PHARMACEUTICALS INC (FUSN) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often FUSION PHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, FUSION PHARMACEUTICALS INC (FUSN) has beaten EPS estimates in 2 out of 4 releases.